US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 22.5300
- +1.8300+8.84%
Close Nov 29 13:00 ET
- 22.2500
- -0.2800-1.24%
Post 17:01 ET
118.91MMarket Cap-11378P/E (TTM)
23.0000High19.8700Low91.01KVolume20.0400Open20.7000Pre Close2.01MTurnover3.64%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High24.04P/B56.27MFloat Cap1.400052wk Low--Dividend TTM2.50MShs Float240.0000Historical High--Div YieldTTM15.12%Amplitude1.3695Historical Low22.0450Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Monopar Therapeutics Stock Forum
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
No comment yet